Laboratory-grown cells have long faced skepticism about whether they truly represent their living counterparts, creating uncertainty for drug development and disease research. This fundamental question now has a more precise answer through artificial intelligence analysis of cellular behavior patterns. Researchers developed a biomedical foundation model to quantitatively compare intestinal epithelial cells grown in laboratory dishes against their natural state within living human tissue. The AI system analyzed massive datasets of cellular characteristics, gene expression patterns, and functional behaviors to create fidelity scores measuring how closely lab cultures mirror authentic biology. The intestinal epithelium served as the test case because of its critical role in nutrient absorption, immune defense, and drug metabolism. The foundation model identified specific culture conditions and timepoints where lab-grown cells achieved highest biological authenticity, providing researchers with concrete benchmarks for experimental design. This breakthrough addresses a persistent challenge in translational medicine where promising laboratory findings often fail in human trials. The quantitative fidelity assessment could revolutionize how researchers validate cell culture systems before investing in expensive clinical development. While focused on intestinal cells, the methodology establishes a framework applicable across tissue types. The approach represents a significant advance beyond traditional visual inspection or limited biomarker comparison, offering comprehensive biological authenticity assessment. However, the model's training data limitations and focus on specific cellular aspects may not capture all relevant biological complexity. This work signals a shift toward more rigorous validation of laboratory models, potentially improving the reliability of preclinical research and reducing the notorious failure rate of therapeutics moving from bench to bedside.